255 related articles for article (PubMed ID: 31999937)
1. Circulating long noncoding RNAs H19 and GAS5 are associated with type 2 diabetes but not with diabetic retinopathy: A preliminary study.
Fawzy MS; Abdelghany AA; Toraih EA; Mohamed AM
Bosn J Basic Med Sci; 2020 Aug; 20(3):365-371. PubMed ID: 31999937
[TBL] [Abstract][Full Text] [Related]
2. Deciphering the role of circulating lncRNAs: RNCR2, NEAT2, CDKN2B-AS1, and PVT1 and the possible prediction of anti-VEGF treatment outcomes in diabetic retinopathy patients.
Toraih EA; Abdelghany AA; Abd El Fadeal NM; Al Ageeli E; Fawzy MS
Graefes Arch Clin Exp Ophthalmol; 2019 Sep; 257(9):1897-1913. PubMed ID: 31327036
[TBL] [Abstract][Full Text] [Related]
3. Circulating long noncoding RNA GAS5 as a potential biomarker in breast cancer for assessing the surgical effects.
Han L; Ma P; Liu SM; Zhou X
Tumour Biol; 2016 May; 37(5):6847-54. PubMed ID: 26662314
[TBL] [Abstract][Full Text] [Related]
4. Expressions of Serum lncRNAs in Diabetic Retinopathy - A Potential Diagnostic Tool.
Biswas S; Coyle A; Chen S; Gostimir M; Gonder J; Chakrabarti S
Front Endocrinol (Lausanne); 2022; 13():851967. PubMed ID: 35464068
[TBL] [Abstract][Full Text] [Related]
5. Effect of metformin on the long non-coding RNA expression levels in type 2 diabetes: an in vitro and clinical trial study.
Parvar SN; Mirzaei A; Zare A; Doustimotlagh AH; Nikooei S; Arya A; Alipoor B
Pharmacol Rep; 2023 Feb; 75(1):189-198. PubMed ID: 36334247
[TBL] [Abstract][Full Text] [Related]
6. Association between lncRNAs in plasma exosomes and diabetic retinopathy.
Ye Q; Li L; Shao Z; Xu M; Li L; Yan Q; Huang B; Zhao T
Front Endocrinol (Lausanne); 2022; 13():987488. PubMed ID: 36187126
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the expression levels of lncRNAs H19 and MEG3 in patients with type 2 diabetes mellitus.
Alrefai AA; Khader HF; Elbasuony HA; Elzorkany KM; Saleh AA
Mol Biol Rep; 2023 Jul; 50(7):6075-6085. PubMed ID: 37294471
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic and prognostic role of serum miR-20b, miR-17-3p, HOTAIR, and MALAT1 in diabetic retinopathy.
Shaker OG; Abdelaleem OO; Mahmoud RH; Abdelghaffar NK; Ahmed TI; Said OM; Zaki OM
IUBMB Life; 2019 Mar; 71(3):310-320. PubMed ID: 30468285
[TBL] [Abstract][Full Text] [Related]
9. Aberrant expression of long noncoding RNAs in early diabetic retinopathy.
Yan B; Tao ZF; Li XM; Zhang H; Yao J; Jiang Q
Invest Ophthalmol Vis Sci; 2014 Feb; 55(2):941-51. PubMed ID: 24436191
[TBL] [Abstract][Full Text] [Related]
10. Effects of Intravitreal Aflibercept on Galectin-1 and Vascular Endothelial Growth Factor-A Plasma Levels in Patients with Diabetic Retinopathy.
Waltl I; Zehetner C; Seifarth C; Handle F; Kieselbach GF; Angermann R; Kralinger MT
Curr Eye Res; 2018 Mar; 43(3):368-375. PubMed ID: 29172741
[TBL] [Abstract][Full Text] [Related]
11. Linking a role of lncRNAs (long non-coding RNAs) with insulin resistance, accelerated senescence, and inflammation in patients with type 2 diabetes.
Sathishkumar C; Prabu P; Mohan V; Balasubramanyam M
Hum Genomics; 2018 Aug; 12(1):41. PubMed ID: 30139387
[TBL] [Abstract][Full Text] [Related]
12. Circulating long noncoding RNA GAS5 levels are correlated to prevalence of type 2 diabetes mellitus.
Carter G; Miladinovic B; Patel AA; Deland L; Mastorides S; Patel NA
BBA Clin; 2015 Dec; 4():102-7. PubMed ID: 26675493
[TBL] [Abstract][Full Text] [Related]
13. Transcriptome analysis identified a novel 3-LncRNA regulatory network of transthyretin attenuating glucose induced hRECs dysfunction in diabetic retinopathy.
Shao J; Zhang Y; Fan G; Xin Y; Yao Y
BMC Med Genomics; 2019 Oct; 12(1):134. PubMed ID: 31615521
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA LY86-AS1 and HCG27_201 expression in type 2 diabetes mellitus.
Saeidi L; Ghaedi H; Sadatamini M; Vahabpour R; Rahimipour A; Shanaki M; Mansoori Z; Kazerouni F
Mol Biol Rep; 2018 Dec; 45(6):2601-2608. PubMed ID: 30328000
[TBL] [Abstract][Full Text] [Related]
15. Decreased H19, GAS5, and linc0597 Expression and Association Analysis of Related Gene Polymorphisms in Rheumatoid Arthritis.
Wu J; Zhang TP; Zhao YL; Li BZ; Leng RX; Pan HF; Ye DQ
Biomolecules; 2019 Dec; 10(1):. PubMed ID: 31905737
[TBL] [Abstract][Full Text] [Related]
16. lncRNA H19 prevents endothelial-mesenchymal transition in diabetic retinopathy.
Thomas AA; Biswas S; Feng B; Chen S; Gonder J; Chakrabarti S
Diabetologia; 2019 Mar; 62(3):517-530. PubMed ID: 30612136
[TBL] [Abstract][Full Text] [Related]
17. Change in Diabetic Retinopathy Through 2 Years: Secondary Analysis of a Randomized Clinical Trial Comparing Aflibercept, Bevacizumab, and Ranibizumab.
Bressler SB; Liu D; Glassman AR; Blodi BA; Castellarin AA; Jampol LM; Kaufman PL; Melia M; Singh H; Wells JA;
JAMA Ophthalmol; 2017 Jun; 135(6):558-568. PubMed ID: 28448655
[TBL] [Abstract][Full Text] [Related]
18. Genetic variants in long noncoding RNA H19 and MEG3 confer risk of type 2 diabetes in an Iranian population.
Ghaedi H; Zare A; Omrani MD; Doustimotlagh AH; Meshkani R; Alipoor S; Alipoor B
Gene; 2018 Oct; 675():265-271. PubMed ID: 29981420
[TBL] [Abstract][Full Text] [Related]
19. Effect of intravitreal conbercept treatment on the expression of Long Noncoding RNAs and mRNAs in Proliferative Diabetic Retinopathy Patients.
Wang J; Gao X; Liu J; Wang J; Zhang Y; Zhang T; Zhang H
Acta Ophthalmol; 2019 Sep; 97(6):e902-e912. PubMed ID: 30900812
[TBL] [Abstract][Full Text] [Related]
20. Alterations of 5-hydroxymethylcytosines in circulating cell-free DNA reflect retinopathy in type 2 diabetes.
Han L; Chen C; Lu X; Song Y; Zhang Z; Zeng C; Chiu R; Li L; Xu M; He C; Zhang W; Duan S
Genomics; 2021 Jan; 113(1 Pt 1):79-87. PubMed ID: 33221518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
